{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S200"
            },
            "ait:date-delivered": {
                "@day": "12",
                "@timestamp": "2023-09-12T05:44:04.000004-04:00",
                "@year": "2023",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Frida Abramov"},
                {"xocs:funding-agency-matched-string": "HBV"},
                {"xocs:funding-agency-matched-string": "John Flaherty"},
                {"xocs:funding-agency-matched-string": "Priyanka Arora"},
                {
                    "xocs:funding-agency-matched-string": "Gilead Sciences",
                    "xocs:funding-agency": "Gilead Sciences",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005564",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-09-12T03:03:05.065Z",
            "xocs:funding-text": [
                {"$": "This study was sponsored by Gilead Sciences. We thank the ALLIANCE study participants, all participating investigators and support staff, and the Gilead Sciences study staff, including Caleb Marceau (HBV clinical virology support), Hui (Cindy) Liu (biostatistics support), John Flaherty, Frida Abramov (HBV scientific support), and Priyanka Arora (clinical pharmacology support). Writing assistance was provided by Jennifer King and Anne Errichelli (Aspire Scientific Limited) on behalf of Gilead Sciences."},
                {"$": "This study was sponsored by Gilead Sciences. We thank the ALLIANCE study participants, all participating investigators and support staff, and the Gilead Sciences study staff, including Caleb Marceau (HBV clinical virology support), Hui (Cindy) Liu (biostatistics support), John Flaherty, Frida Abramov (HBV scientific support), and Priyanka Arora (clinical pharmacology support). Writing assistance was provided by Jennifer King and Anne Errichelli (Aspire Scientific Limited) on behalf of Gilead Sciences."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60016965",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "HIV-NAT"},
                                {"$": "Thai Red Cross AIDS Research Centre"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60016965"},
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950587919-03b414e37d862229b8b607b57af154d0-1",
                            "ce:source-text": "HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Anchalee",
                            "preferred-name": {
                                "ce:given-name": "Anchalee",
                                "ce:initials": "A.",
                                "ce:surname": "Avihingsanon",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-f14372cb1b1143d14566c8782a393fb5-1",
                            "@seq": "1",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Avihingsanon",
                            "@auid": "57196347321",
                            "ce:indexed-name": "Avihingsanon A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Tuberculosis"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "127930228"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950587919-97ebd41f4b45cb3b4b9e404a0c635085-1",
                            "ce:source-text": "Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "127930228"
                        },
                        "author": [{
                            "ce:given-name": "Anchalee",
                            "preferred-name": {
                                "ce:given-name": "Anchalee",
                                "ce:initials": "A.",
                                "ce:surname": "Avihingsanon",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-f14372cb1b1143d14566c8782a393fb5-1",
                            "@seq": "1",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Avihingsanon",
                            "@auid": "57196347321",
                            "ce:indexed-name": "Avihingsanon A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "128470234",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": {"$": "Shanghai Public Health Clinical Centre"},
                            "affiliation-id": {"@afid": "128470234"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-e0055361b9ff7c6147ab7afde51675dc-1",
                            "ce:source-text": "Shanghai Public Health Clinical Centre, Shanghai, China"
                        },
                        "author": [{
                            "ce:given-name": "Hongzhou",
                            "preferred-name": {
                                "ce:given-name": "Hongzhou",
                                "ce:initials": "H.",
                                "ce:surname": "Lu",
                                "ce:indexed-name": "Lu H."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-05ffe11380abefc748c781afe63d3c25-1",
                            "@seq": "2",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Lu",
                            "@auid": "58565355200",
                            "ce:indexed-name": "Lu H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60025530",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Kuala Lumpur General Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60025530",
                                "@dptid": "104293276"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950587919-d8fd196d636f80c8241ce347b29de3ea-1",
                            "ce:source-text": "Department of Medicine, Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia",
                            "@dptid": "104293276"
                        },
                        "author": [{
                            "ce:given-name": "Chee Loon",
                            "preferred-name": {
                                "ce:given-name": "Chee Loon",
                                "ce:initials": "C.L.",
                                "ce:surname": "Leong",
                                "ce:indexed-name": "Leong C.L."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-2a3504d182d24952850d26579de6273f-1",
                            "@seq": "3",
                            "ce:initials": "C.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Leong",
                            "@auid": "58565355300",
                            "ce:indexed-name": "Leong C.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073385",
                            "@country": "twn",
                            "city": "Yunlin",
                            "organization": {"$": "National Taiwan University Hospital"},
                            "affiliation-id": {"@afid": "60073385"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-be897edaa424038de9f5ee0148553d98-1",
                            "ce:source-text": "National Taiwan University Hospital, Yunlin, Taiwan"
                        },
                        "author": [{
                            "ce:given-name": "Chien-Ching",
                            "preferred-name": {
                                "ce:given-name": "Chien Ching",
                                "ce:initials": "C.C.",
                                "ce:surname": "Hung",
                                "ce:indexed-name": "Hung C.C."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-6bf680e78b1e7148ffe87d86da6be138-1",
                            "@seq": "4",
                            "ce:initials": "C.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Hung",
                            "@auid": "7403166331",
                            "ce:indexed-name": "Hung C.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Dominican Republic",
                            "@afid": "120832939",
                            "@country": "dom",
                            "city": "Santo Domingo",
                            "organization": {"$": "Dominican Institute of Virological Studies"},
                            "affiliation-id": {"@afid": "120832939"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-5d4bb55b3b66671ec6a20833348d0a11-1",
                            "ce:source-text": "Dominican Institute of Virological Studies, Santo Domingo, Dominican Republic"
                        },
                        "author": [{
                            "ce:given-name": "Ellen",
                            "preferred-name": {
                                "ce:given-name": "Ellen",
                                "ce:initials": "E.",
                                "ce:surname": "Koenig",
                                "ce:indexed-name": "Koenig E."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-1f1ee12736c843288bf7c172cadf8486-1",
                            "@seq": "5",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Koenig",
                            "@auid": "7005320371",
                            "ce:indexed-name": "Koenig E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125771232"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950587919-dbb0586828a2ab95d7bd56792b6c6276-1",
                            "ce:source-text": "Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125771232"
                        },
                        "author": [{
                            "ce:given-name": "Sasisopin",
                            "preferred-name": {
                                "ce:given-name": "Sasisopin",
                                "ce:initials": "S.",
                                "ce:surname": "Kiertiburanakul",
                                "ce:indexed-name": "Kiertiburanakul S."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-155914685d9b2a210559b52d4a7cc656-1",
                            "@seq": "6",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Kiertiburanakul",
                            "@auid": "6506539792",
                            "ce:indexed-name": "Kiertiburanakul S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "address-part": "Hong Kong Special Administrative Region",
                            "@afid": "60014234",
                            "@country": "chn",
                            "organization": {"$": "Queen Elizabeth Hospital"},
                            "affiliation-id": {"@afid": "60014234"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-0ee5fa28e923a1bb8cd0ee5f8ea8dcc2-1",
                            "ce:source-text": "Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China"
                        },
                        "author": [{
                            "ce:given-name": "Man-Po",
                            "preferred-name": {
                                "ce:given-name": "Man Po",
                                "ce:initials": "M.P.",
                                "ce:surname": "Lee",
                                "ce:indexed-name": "Lee M.P."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-bcbe3305870cf4bc722969b08cc2c377-1",
                            "@seq": "7",
                            "ce:initials": "M.-P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MBBS",
                            "ce:surname": "Lee",
                            "@auid": "56143671100",
                            "ce:indexed-name": "Lee M.-P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": {"$": "Chiang Mai University"},
                            "affiliation-id": {"@afid": "60000881"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-9fe2dafd2249b631bdd0853972565676-1",
                            "ce:source-text": "Chiang Mai University, Chiang Mai, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Khuanchai",
                            "preferred-name": {
                                "ce:given-name": "Khuanchai",
                                "ce:initials": "K.",
                                "ce:surname": "Supparatpinyo",
                                "ce:indexed-name": "Supparatpinyo K."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-e27b2bec7a8baa168d4f468b40f26e72-1",
                            "@seq": "8",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Supparatpinyo",
                            "@auid": "6602542079",
                            "ce:indexed-name": "Supparatpinyo K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073434",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": [
                                {"$": "Beijing Ditan Hospital"},
                                {"$": "Capital Medical University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60073434"},
                                {"@afid": "60026707"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950587919-def1dbc458e7c623e7e151d04ddfa811-1",
                            "ce:source-text": "Beijing Ditan Hospital, Capital Medical University, Beijing, China"
                        },
                        "author": [{
                            "ce:given-name": "Fujie",
                            "preferred-name": {
                                "ce:given-name": "Fujie",
                                "ce:initials": "F.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang F."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-c1af1add1e55f49a09c30421d3a5c235-1",
                            "@seq": "9",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Zhang",
                            "@auid": "55503803800",
                            "ce:indexed-name": "Zhang F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002909",
                            "@country": "usa",
                            "city": "Foster City",
                            "organization": {"$": "Gilead Sciences"},
                            "affiliation-id": {"@afid": "60002909"},
                            "state": "CA",
                            "@affiliation-instance-id": "OB2BibRecID-950587919-96534d9ad03da7c9218f18f9eee03afd-1",
                            "ce:source-text": "Gilead Sciences, Foster City, CA, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "Sophia",
                                "preferred-name": {
                                    "ce:given-name": "Sophia",
                                    "ce:initials": "S.",
                                    "ce:surname": "Rahman",
                                    "ce:indexed-name": "Rahman S."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-d094fcf9ac900a713ec5ab05c04abc34-1",
                                "@seq": "10",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MPH",
                                "ce:surname": "Rahman",
                                "@auid": "58565182900",
                                "ce:indexed-name": "Rahman S."
                            },
                            {
                                "ce:given-name": "Michelle L",
                                "preferred-name": {
                                    "ce:given-name": "Michelle L.",
                                    "ce:initials": "M.L.",
                                    "ce:surname": "D'Antoni",
                                    "ce:indexed-name": "D'Antoni M.L."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-483ec91c270e8aebc49d28c2172cc255-1",
                                "@seq": "11",
                                "ce:initials": "M.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "D'Antoni",
                                "@auid": "24068794700",
                                "ce:indexed-name": "D'Antoni M.L."
                            },
                            {
                                "ce:given-name": "Hongyuan",
                                "preferred-name": {
                                    "ce:given-name": "Hongyuan",
                                    "ce:initials": "H.",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang H."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-cb45293e87bf9591c8c03d2b08a6008e-1",
                                "@seq": "12",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Wang",
                                "@auid": "58566213400",
                                "ce:indexed-name": "Wang H."
                            },
                            {
                                "ce:given-name": "Jason T",
                                "preferred-name": {
                                    "ce:given-name": "Jason T.",
                                    "ce:initials": "J.T.",
                                    "ce:surname": "Hindman",
                                    "ce:indexed-name": "Hindman J.T."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-351fbad0210e9d3cc07f434a5c2c0619-1",
                                "@seq": "13",
                                "ce:initials": "J.T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PharmD",
                                "ce:surname": "Hindman",
                                "@auid": "53864807100",
                                "ce:indexed-name": "Hindman J.T."
                            },
                            {
                                "ce:given-name": "Hal",
                                "preferred-name": {
                                    "ce:given-name": "Hal",
                                    "ce:initials": "H.",
                                    "ce:surname": "Martin",
                                    "ce:indexed-name": "Martin H."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-855a1fac28a937ffbbefbee7d6fabdb3-1",
                                "@seq": "14",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Martin",
                                "@auid": "56173399700",
                                "ce:indexed-name": "Martin H."
                            },
                            {
                                "ce:given-name": "Jared M",
                                "preferred-name": {
                                    "ce:given-name": "Jared M.",
                                    "ce:initials": "J.M.",
                                    "ce:surname": "Baeten",
                                    "ce:indexed-name": "Baeten J.M."
                                },
                                "@author-instance-id": "OB2BibRecID-950587919-e4c642acb2ba7fc74bf93315b84d4ca7-1",
                                "@seq": "15",
                                "ce:initials": "J.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Baeten",
                                "@auid": "7003812564",
                                "ce:indexed-name": "Baeten J.M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60008706",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": {"$": "Peking Union Medical College Hospital"},
                            "affiliation-id": {"@afid": "60008706"},
                            "@affiliation-instance-id": "OB2BibRecID-950587919-7e1f01dfa9ce5a2e0c200cd7a446d56f-1",
                            "ce:source-text": "Peking Union Medical College Hospital, Beijing, China"
                        },
                        "author": [{
                            "ce:given-name": "Taisheng",
                            "preferred-name": {
                                "ce:given-name": "Taisheng",
                                "ce:initials": "T.",
                                "ce:surname": "Li",
                                "ce:indexed-name": "Li T."
                            },
                            "@author-instance-id": "OB2BibRecID-950587919-2d841b0f7a89e9bdab173bd850613e83-1",
                            "@seq": "16",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Li",
                            "@auid": "8876653800",
                            "ce:indexed-name": "Li T."
                        }]
                    },
                    {"collaboration": {
                        "@seq": "17",
                        "@collaboration-instance-id": "OB2BibRecID-950587919-97055efb65137c40b86c910a8e722c34-1",
                        "ce:text": "ALLIANCE Study Team",
                        "ce:indexed-name": "ALLIANCE Study Team"
                    }}
                ],
                "citation-title": "Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial",
                "abstracts": "© 2023 Elsevier LtdBackground: For most adults with HIV-1 and hepatitis B virus (HBV) coinfection, initial recommended treatment is a tenofovir-containing antiretroviral regimen, but no randomised studies have compared tenofovir disoproxil fumarate with tenofovir alafenamide. We aimed to investigate whether bictegravir, emtricitabine, and tenofovir alafenamide is non-inferior to dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for viral suppression in individuals with HIV-1 and HBV coinfection at 48 and 96 weeks. Methods: We did this randomised, double-blind, active-controlled, phase 3, non-inferiority trial at 46 outpatient centres in China, Dominican Republic, Hong Kong, Japan, Malaysia, South Korea, Spain, Taiwan, Thailand, Turkey, and the USA. Eligible participants were treatment-naive adults (aged ≥18 years) with plasma HIV-1 RNA of at least 500 copies per mL and plasma HBV DNA of at least 2000 IU/mL. Participants were randomly assigned (1:1) to receive daily oral bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, or dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir disoproxil fumarate 300 mg, each with corresponding matching placebo. Randomisation was stratified by hepatitis B e antigen (HBeAg) status (positive vs negative), HBV DNA (<8 vs ≥8 log10 IU/mL), and CD4 count (<50 vs ≥50 cells per μL) at screening. All investigators, participants, and staff providing treatment, assessing outcomes, and collecting data were masked to study treatment for 96 weeks. Coprimary endpoints were the proportion of participants with plasma HIV-1 RNA less than 50 copies per mL (defined by the US Food and Drug Administration snapshot algorithm) and plasma HBV DNA less than 29 IU/mL (using the missing-equals-failure approach) at week 48, with a prespecified non-inferiority margin of \u201312%. Coprimary endpoints were assessed in the full analysis set, which included all randomly assigned participants who received at least one dose of study drug and had at least one post-baseline HIV-1 RNA or HBV DNA result while on study drug. Safety endpoints were assessed in all randomly assigned participants who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, NCT03547908. Findings: Between May 30, 2018 and March 16, 2021, 381 participants were screened, of whom 243 initiated treatment (121 in the receive bictegravir, emtricitabine, and tenofovir alafenamide group; 122 in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group). At week 48, both endpoints met the criteria for non-inferiority: 113 (95%) of 119 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group and 111 (91%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group had HIV-1 RNA less than 50 copies per mL (difference 4·1, 95% CI −2·5 to 10·8; p=0·21), and 75 (63%) of 119 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group versus 53 (43%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group had HBV DNA suppression (difference 16·6, 5·9 to 27·3; nominal p=0·0023). Drug-related adverse events up to week 96 occurred in 35 (29%) of 121 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group and 34 (28%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group. One (1%) of 121 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group reported a serious adverse event (cryptococcal meningitis attributed to immune reconstitution inflammatory syndrome) that was deemed to be treatment-related. Interpretation: Coformulated bictegravir, emtricitabine, and tenofovir alafenamide is an effective therapy for adults with HIV-1 and HBV coinfection starting antiviral therapy. Funding: Gilead Sciences.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "postal-code": "94404",
                        "@country": "usa",
                        "city": "Foster City",
                        "organization": {"$": "Gilead Sciences"},
                        "state": "CA",
                        "@affiliation-instance-id": "OB2BibRecID-950587919-81602e7f829b3e9b6bfbcc9e51c907e1-1"
                    },
                    "person": {
                        "ce:given-name": "Jason T",
                        "@author-instance-id": "OB2BibRecID-950587919-8600c46a4f680a4b25ae2aba80bf9d63-1",
                        "ce:initials": "J.T.",
                        "ce:degrees": "PharmD",
                        "ce:surname": "Hindman",
                        "ce:indexed-name": "Hindman J.T."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Lancet HIV",
                    "website": {"ce:e-address": {
                        "$": "http://www.journals.elsevier.com/the-lancet-hiv/",
                        "@type": "email"
                    }},
                    "@country": "gbr",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "23523018",
                        "@type": "electronic"
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier Ltd"},
                    "sourcetitle": "The Lancet HIV",
                    "@srcid": "21100369870",
                    "publicationdate": {
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2023"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": [
                            {"$": "2713"},
                            {"$": "2403"},
                            {"$": "2725"},
                            {"$": "2406"}
                        ]
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": [
                            {"$": "MEDI"},
                            {"$": "IMMU"}
                        ]
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was sponsored by Gilead Sciences. We thank the ALLIANCE study participants, all participating investigators and support staff, and the Gilead Sciences study staff, including Caleb Marceau (HBV clinical virology support), Hui (Cindy) Liu (biostatistics support), John Flaherty, Frida Abramov (HBV scientific support), and Priyanka Arora (clinical pharmacology support). Writing assistance was provided by Jennifer King and Anne Errichelli (Aspire Scientific Limited) on behalf of Gilead Sciences.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "Publisher",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "11",
                    "@timestamp": "BST 08:15:48",
                    "@year": "2023",
                    "@month": "09"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2026821158",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "641882545",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "950587919",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230840241",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37494942",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2023374166",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20232709287",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20233375474",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2023121726",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "85169916784",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85169916784",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:pii": "S2352301823001510",
                    "ce:ern": "pii:S2352301823001510",
                    "ce:doi": "10.1016/S2352-3018(23)00151-0"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "30",
                "reference": [
                    {
                        "ref-fulltext": "Platt, L, French, CE, McGowan, CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepat 27 (2020), 294\u2013315.",
                        "@reference-instance-id": "OB2BibRecID-950587919-7bc060d7a60935708b60343e51eeb813-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076898333",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "294",
                                    "@last": "315"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Platt",
                                        "ce:indexed-name": "Platt L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.E.",
                                        "@_fa": "true",
                                        "ce:surname": "French",
                                        "ce:indexed-name": "French C.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.R.",
                                        "@_fa": "true",
                                        "ce:surname": "McGowan",
                                        "ce:indexed-name": "McGowan C.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Viral Hepat"
                        },
                        "ce:source-text": "Platt L, French CE, McGowan CR, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepat 2020; 27: 294\u2013315."
                    },
                    {
                        "ref-fulltext": "Singh, KP, Crane, M, Audsley, J, Avihingsanon, A, Sasadeusz, J, Lewin, SR, HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 31 (2017), 2035\u20132052.",
                        "@reference-instance-id": "OB2BibRecID-950587919-4b23e64b5d21f7dfdc4241e7f0624378-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021967294",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "2035",
                                    "@last": "2052"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Singh",
                                    "ce:indexed-name": "Singh K.P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Crane",
                                    "ce:indexed-name": "Crane M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Audsley",
                                    "ce:indexed-name": "Audsley J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sasadeusz",
                                    "ce:indexed-name": "Sasadeusz J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Lewin",
                                    "ce:indexed-name": "Lewin S.R."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 2017; 31: 2035\u201352."
                    },
                    {
                        "ref-fulltext": "Vinikoor, MJ, Sinkala, E, Chilengi, R, et al. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia. Clin Infect Dis 64 (2017), 1343\u20131349.",
                        "@reference-instance-id": "OB2BibRecID-950587919-5c0360e97bc487591a46b10a7fc9d5ba-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019164081",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1343",
                                    "@last": "1349"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Vinikoor",
                                        "ce:indexed-name": "Vinikoor M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sinkala",
                                        "ce:indexed-name": "Sinkala E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Chilengi",
                                        "ce:indexed-name": "Chilengi R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Vinikoor MJ, Sinkala E, Chilengi R, et al. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia. Clin Infect Dis 2017; 64: 1343\u201349."
                    },
                    {
                        "ref-fulltext": "Cheng, Z, Lin, P, Cheng, N, HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med, 8, 2021, 713981.",
                        "@reference-instance-id": "OB2BibRecID-950587919-90cf0880eea14e3dba0442f706ff5bde-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "713981",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85117227551",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "8"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheng",
                                    "ce:indexed-name": "Cheng Z."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheng",
                                    "ce:indexed-name": "Cheng N."
                                }
                            ]},
                            "ref-sourcetitle": "Front Med"
                        },
                        "ce:source-text": "Cheng Z, Lin P, Cheng N. HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases. Front Med 2021; 8: 713981."
                    },
                    {
                        "ref-fulltext": "Boyd, A, Dezanet, LNC, Lacombe, K, Functional cure of hepatitis B virus infection in individuals with HIV-coinfection: a literature review. Viruses, 13, 2021, 1341.",
                        "@reference-instance-id": "OB2BibRecID-950587919-5b1f683f3f84428c3bd83eca1624ff03-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Functional cure of hepatitis B virus infection in individuals with HIV-coinfection: a literature review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "1341",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85111071588",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "13"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Boyd",
                                    "ce:indexed-name": "Boyd A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.N.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Dezanet",
                                    "ce:indexed-name": "Dezanet L.N.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Lacombe",
                                    "ce:indexed-name": "Lacombe K."
                                }
                            ]},
                            "ref-sourcetitle": "Viruses"
                        },
                        "ce:source-text": "Boyd A, Dezanet LNC, Lacombe K. Functional cure of hepatitis B virus infection in individuals with HIV-coinfection: a literature review. Viruses 2021; 13: 1341."
                    },
                    {
                        "ref-fulltext": "WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. https://www.who.int/publications/i/item/9789240031593, July 16, 2021. (Accessed 30 March 2022)",
                        "@reference-instance-id": "OB2BibRecID-950587919-cfbde5e7204b0bdbb669d64225e05467-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.who.int/publications/i/item/9789240031593",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85113678030",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 30 March 2022)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "WHO",
                                "ce:indexed-name": "WHO"
                            }}
                        },
                        "ce:source-text": "WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. July 16, 2021. https://www.who.int/publications/i/item/9789240031593 (accessed March 30, 2022)."
                    },
                    {
                        "ref-fulltext": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv. (Accessed 28 June 2022)",
                        "@reference-instance-id": "OB2BibRecID-950587919-2e7b5013473a47a8459233e86807c226-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85160100239",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 28 June 2022)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Panel on Antiretroviral Guidelines for Adults and Adolescents",
                                "ce:indexed-name": "Panel on Antiretroviral Guidelines for Adults and Adolescents"
                            }}
                        },
                        "ce:source-text": "Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv (accessed June 28, 2022)."
                    },
                    {
                        "ref-fulltext": "Buti, M, Gane, E, Seto, WK, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 1 (2016), 196\u2013206.",
                        "@reference-instance-id": "OB2BibRecID-950587919-aa745a834fbba999bacc15511e14889c-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84996538096",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "196",
                                    "@last": "206"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Buti",
                                        "ce:indexed-name": "Buti M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Gane",
                                        "ce:indexed-name": "Gane E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Seto",
                                        "ce:indexed-name": "Seto W.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Buti M, Gane E, Seto WK, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 2016; 1: 196\u2013206."
                    },
                    {
                        "ref-fulltext": "Chan, HLY, Fung, S, Seto, WK, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 1 (2016), 185\u2013195.",
                        "@reference-instance-id": "OB2BibRecID-950587919-3118ab91d49ce785143063b3bcc7cff0-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84996520524",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "185",
                                    "@last": "195"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.L.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan H.L.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fung",
                                        "ce:indexed-name": "Fung S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Seto",
                                        "ce:indexed-name": "Seto W.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Chan HLY, Fung S, Seto WK, et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol 2016; 1: 185\u201395."
                    },
                    {
                        "ref-fulltext": "Marcellin, P, Heathcote, EJ, Buti, M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 359 (2008), 2442\u20132455.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ea331bfc92878a7d5f2477aa8bdb37d9-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57349095400",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "2442",
                                    "@last": "2455"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Marcellin",
                                        "ce:indexed-name": "Marcellin P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Heathcote",
                                        "ce:indexed-name": "Heathcote E.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Buti",
                                        "ce:indexed-name": "Buti M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008; 359: 2442\u201355."
                    },
                    {
                        "ref-fulltext": "Di Perri, G, Tenofovir alafenamide (TAF) clinical pharmacology. Infez Med 29 (2021), 526\u2013529.",
                        "@reference-instance-id": "OB2BibRecID-950587919-6b4b322da261f1107508b2b919c9bdf0-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Tenofovir alafenamide (TAF) clinical pharmacology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85121276560",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "526",
                                    "@last": "529"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "G.",
                                "@_fa": "true",
                                "ce:surname": "Di Perri",
                                "ce:indexed-name": "Di Perri G."
                            }]},
                            "ref-sourcetitle": "Infez Med"
                        },
                        "ce:source-text": "Di Perri G. Tenofovir alafenamide (TAF) clinical pharmacology. Infez Med 2021; 29: 526\u201329."
                    },
                    {
                        "ref-fulltext": "Gallant, J, Brunetta, J, Crofoot, G, et al. Efficacy and safety of switching to a single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-1/hepatitis B-coinfected adults. J Acquir Immune Defic Syndr 73 (2016), 294\u2013298.",
                        "@reference-instance-id": "OB2BibRecID-950587919-d017664ca0cd8d0fab0b6bf290f4ad81-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of switching to a single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-1/hepatitis B-coinfected adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84966709419",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "294",
                                    "@last": "298"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gallant",
                                        "ce:indexed-name": "Gallant J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Brunetta",
                                        "ce:indexed-name": "Brunetta J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Crofoot",
                                        "ce:indexed-name": "Crofoot G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Gallant J, Brunetta J, Crofoot G, et al. Efficacy and safety of switching to a single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-1/hepatitis B-coinfected adults. J Acquir Immune Defic Syndr 2016; 73: 294\u201398."
                    },
                    {
                        "ref-fulltext": "Benhamou, Y, Fleury, H, Trimoulet, P, et al. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology 43 (2006), 548\u2013555.",
                        "@reference-instance-id": "OB2BibRecID-950587919-7cee4d786981661eed97f870f048c970-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33645215806",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "548",
                                    "@last": "555"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Benhamou",
                                        "ce:indexed-name": "Benhamou Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Fleury",
                                        "ce:indexed-name": "Fleury H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Trimoulet",
                                        "ce:indexed-name": "Trimoulet P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Benhamou Y, Fleury H, Trimoulet P, et al. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology 2006; 43: 548\u201355."
                    },
                    {
                        "ref-fulltext": "Gallant, J, Lazzarin, A, Mills, A, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet 390 (2017), 2063\u20132072.",
                        "@reference-instance-id": "OB2BibRecID-950587919-25e09a916497d81382e174146fcb9e90-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028623606",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "390"},
                                "pagerange": {
                                    "@first": "2063",
                                    "@last": "2072"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gallant",
                                        "ce:indexed-name": "Gallant J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lazzarin",
                                        "ce:indexed-name": "Lazzarin A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Mills",
                                        "ce:indexed-name": "Mills A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Gallant J, Lazzarin A, Mills A, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet 2017; 390: 2063\u201372."
                    },
                    {
                        "ref-fulltext": "Sax, PE, Pozniak, A, Montes, ML, et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet 390 (2017), 2073\u20132082.",
                        "@reference-instance-id": "OB2BibRecID-950587919-c74cca24237dd5c57735898ac6b3ebcd-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028684793",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "390"},
                                "pagerange": {
                                    "@first": "2073",
                                    "@last": "2082"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sax",
                                        "ce:indexed-name": "Sax P.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Pozniak",
                                        "ce:indexed-name": "Pozniak A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Montes",
                                        "ce:indexed-name": "Montes M.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Sax PE, Pozniak A, Montes ML, et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet 2017; 390: 2073\u201382."
                    },
                    {
                        "ref-fulltext": "Surial, B, Béguelin, C, Chave, JP, et al. Brief report: Switching from TDF to TAF in HIV/HBV-coinfected individuals with renal dysfunction-a prospective cohort study. J Acquir Immune Defic Syndr 85 (2020), 227\u2013232.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ba514db3b2e707bf4d691a1043cca4dd-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Brief report: Switching from TDF to TAF in HIV/HBV-coinfected individuals with renal dysfunction-a prospective cohort study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85090947023",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "85"},
                                "pagerange": {
                                    "@first": "227",
                                    "@last": "232"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Surial",
                                        "ce:indexed-name": "Surial B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Béguelin",
                                        "ce:indexed-name": "Beguelin C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chave",
                                        "ce:indexed-name": "Chave J.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Surial B, Béguelin C, Chave JP, et al. Brief report: Switching from TDF to TAF in HIV/HBV-coinfected individuals with renal dysfunction-a prospective cohort study. J Acquir Immune Defic Syndr 2020; 85: 227\u201332."
                    },
                    {
                        "ref-fulltext": "Sarowar, A, Coffin, CS, Fung, S, et al. Brief report: effect of antiretroviral switch from tenofovir disoproxil fumarate to tenofovir alafenamide on alanine aminotransferase, lipid profiles, and renal function in HIV/HBV-coinfected individuals in a nationwide Canadian study. J Acquir Immune Defic Syndr 91 (2022), 368\u2013372.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ea872f733eb37ab47faeb04540e73ba6-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Brief report: effect of antiretroviral switch from tenofovir disoproxil fumarate to tenofovir alafenamide on alanine aminotransferase, lipid profiles, and renal function in HIV/HBV-coinfected individuals in a nationwide Canadian study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85140810135",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "91"},
                                "pagerange": {
                                    "@first": "368",
                                    "@last": "372"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sarowar",
                                        "ce:indexed-name": "Sarowar A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Coffin",
                                        "ce:indexed-name": "Coffin C.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fung",
                                        "ce:indexed-name": "Fung S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Sarowar A, Coffin CS, Fung S, et al. Brief report: effect of antiretroviral switch from tenofovir disoproxil fumarate to tenofovir alafenamide on alanine aminotransferase, lipid profiles, and renal function in HIV/HBV-coinfected individuals in a nationwide Canadian study. J Acquir Immune Defic Syndr 2022; 91: 368\u201372."
                    },
                    {
                        "ref-fulltext": "Rockstroh J, Sax PE, Daar E, et al. High HBV and HIV suppression with treatment of HIV/HBV coinfection in B/F/TAF studies. Conference on Retroviruses and Opportunistic Infections; March 4\u20137, 2018. Boston, MA, USA (abstr 618).",
                        "@reference-instance-id": "OB2BibRecID-950587919-7a510888bbb14f79e86457b626cd09e5-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85170049117",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "High HBV and HIV suppression with treatment of HIV/HBV coinfection in B/F/TAF studies. Conference on Retroviruses and Opportunistic Infections; March 4\u20137 Boston, MA, USA (abstr 618).",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Rockstroh",
                                        "ce:indexed-name": "Rockstroh J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sax",
                                        "ce:indexed-name": "Sax P.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Daar",
                                        "ce:indexed-name": "Daar E."
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Rockstroh J, Sax PE, Daar E, et al. High HBV and HIV suppression with treatment of HIV/HBV coinfection in B/F/TAF studies. Conference on Retroviruses and Opportunistic Infections; March 4\u20137, 2018. Boston, MA, USA (abstr 618)."
                    },
                    {
                        "ref-fulltext": "Wohl, DA, Yazdanpanah, Y, Baumgarten, A, et al. Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV 6 (2019), e355\u2013e363.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ff68c53dbc5070e73885bbbb8164592d-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066295031",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "e355",
                                    "@last": "e363"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Wohl",
                                        "ce:indexed-name": "Wohl D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yazdanpanah",
                                        "ce:indexed-name": "Yazdanpanah Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Baumgarten",
                                        "ce:indexed-name": "Baumgarten A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet HIV"
                        },
                        "ce:source-text": "Wohl DA, Yazdanpanah Y, Baumgarten A, et al. Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV 2019; 6: e355\u201363."
                    },
                    {
                        "ref-fulltext": "Orkin, C, DeJesus, E, Sax, PE, et al. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. Lancet HIV 7 (2020), e389\u2013e400.",
                        "@reference-instance-id": "OB2BibRecID-950587919-b09dd6d45292d3cf2198624e27f21eb5-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085644946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "e389",
                                    "@last": "e400"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Orkin",
                                        "ce:indexed-name": "Orkin C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "DeJesus",
                                        "ce:indexed-name": "DeJesus E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sax",
                                        "ce:indexed-name": "Sax P.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet HIV"
                        },
                        "ce:source-text": "Orkin C, DeJesus E, Sax PE, et al. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. Lancet HIV 2020; 7: e389\u2013400."
                    },
                    {
                        "ref-fulltext": "Clay, PG, Yuet, WC, Moecklinghoff, CH, et al. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Res Ther, 15, 2018, 17.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ece9932fa283c961b7426081242f638a-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055614378",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "17"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Clay",
                                        "ce:indexed-name": "Clay P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Yuet",
                                        "ce:indexed-name": "Yuet W.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Moecklinghoff",
                                        "ce:indexed-name": "Moecklinghoff C.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Res Ther"
                        },
                        "ce:source-text": "Clay PG, Yuet WC, Moecklinghoff CH, et al. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Res Ther 2018; 15: 17."
                    },
                    {
                        "ref-fulltext": "US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research. Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry. https://www.fda.gov/media/86284/download, 2015. (Accessed 23 March 2023)",
                        "@reference-instance-id": "OB2BibRecID-950587919-a0976876a923b4e36043ac6e2a062507-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/media/86284/download",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018054863",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 23 March 2023)",
                            "ref-authors": {"collaboration": [
                                {
                                    "@seq": "1",
                                    "ce:text": "US Department of Health and Human Services Food and Drug Administration",
                                    "ce:indexed-name": "US Department of Health and Human Services Food and Drug Administration"
                                },
                                {
                                    "@seq": "2",
                                    "ce:text": "Center for Drug Evaluation and Research",
                                    "ce:indexed-name": "Center for Drug Evaluation and Research"
                                }
                            ]}
                        },
                        "ce:source-text": "US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research. Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment. Guidance for industry. 2015. https://www.fda.gov/media/86284/download (accessed March 23, 2023)."
                    },
                    {
                        "ref-fulltext": "Terrault, NA, Lok, ASF, McMahon, BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67 (2018), 1560\u20131599.",
                        "@reference-instance-id": "OB2BibRecID-950587919-86c22ddefb65084865028753208a47c6-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044252801",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "1560",
                                    "@last": "1599"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Terrault",
                                        "ce:indexed-name": "Terrault N.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.S.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Lok",
                                        "ce:indexed-name": "Lok A.S.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.J.",
                                        "@_fa": "true",
                                        "ce:surname": "McMahon",
                                        "ce:indexed-name": "McMahon B.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560\u201399."
                    },
                    {
                        "ref-fulltext": "Agarwal, K, Brunetto, M, Seto, WK, et al. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. J Hepatol 68 (2018), 672\u2013681.",
                        "@reference-instance-id": "OB2BibRecID-950587919-4dce273cc3d28d6f978fb421ac6dbe32-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041127106",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "672",
                                    "@last": "681"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Agarwal",
                                        "ce:indexed-name": "Agarwal K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Brunetto",
                                        "ce:indexed-name": "Brunetto M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Seto",
                                        "ce:indexed-name": "Seto W.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Agarwal K, Brunetto M, Seto WK, et al. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. J Hepatol 2018; 68: 672\u201381."
                    },
                    {
                        "ref-fulltext": "Maurer, W, Hothorn, L, Lehmacher, W, Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. Vollmar, J, (eds.) Biometrie in der Chemisch-Pharmazeutischen Industrie, 1995, Fischer Verlag, Stuttgart, 3\u201318.",
                        "@reference-instance-id": "OB2BibRecID-950587919-ecb73e5c1edad1a948ba21496475711d-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1995"},
                            "ref-title": {"ref-titletext": "Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0002676309",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "3",
                                "@last": "18"
                            }},
                            "ref-text": "J Vollmar Fischer Verlag Stuttgart",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Maurer",
                                    "ce:indexed-name": "Maurer W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Hothorn",
                                    "ce:indexed-name": "Hothorn L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Lehmacher",
                                    "ce:indexed-name": "Lehmacher W."
                                }
                            ]},
                            "ref-sourcetitle": "Biometrie in der Chemisch-Pharmazeutischen Industrie"
                        },
                        "ce:source-text": "Maurer W, Hothorn L, Lehmacher W. Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollmar J, ed. Biometrie in der Chemisch-Pharmazeutischen Industrie. Stuttgart: Fischer Verlag, 1995: 3\u201318."
                    },
                    {
                        "ref-fulltext": "Price, H, Dunn, D, Pillay, D, et al. Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. PLoS One, 8, 2013, e68152.",
                        "@reference-instance-id": "OB2BibRecID-950587919-d3e80a3fce6a6241fa95150ad3fe7e18-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e68152",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84880016598",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "8"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Price",
                                        "ce:indexed-name": "Price H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dunn",
                                        "ce:indexed-name": "Dunn D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Pillay",
                                        "ce:indexed-name": "Pillay D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Price H, Dunn D, Pillay D, et al. Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. PLoS One 2013; 8: e68152."
                    },
                    {
                        "ref-fulltext": "van Bremen, K, Hoffmann, C, Mauss, S, et al. Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection. Liver Int 40 (2020), 2978\u20132981.",
                        "@reference-instance-id": "OB2BibRecID-950587919-7108ab9b57f320813de3cb402caf48d7-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092628890",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "2978",
                                    "@last": "2981"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "van Bremen",
                                        "ce:indexed-name": "van Bremen K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hoffmann",
                                        "ce:indexed-name": "Hoffmann C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mauss",
                                        "ce:indexed-name": "Mauss S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Liver Int"
                        },
                        "ce:source-text": "van Bremen K, Hoffmann C, Mauss S, et al. Obstacles to HBV functional cure: late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection. Liver Int 2020; 40: 2978\u201381."
                    },
                    {
                        "ref-fulltext": "Liaw, YF, HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 3 (2009), 425\u2013433.",
                        "@reference-instance-id": "OB2BibRecID-950587919-af24fa1b37b772fe9acb4ddf7317775c-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68949146886",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "425",
                                    "@last": "433"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "Y.F.",
                                "@_fa": "true",
                                "ce:surname": "Liaw",
                                "ce:indexed-name": "Liaw Y.F."
                            }]},
                            "ref-sourcetitle": "Hepatol Int"
                        },
                        "ce:source-text": "Liaw YF. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 2009; 3: 425\u201333."
                    },
                    {
                        "ref-fulltext": "Moini, M, Fung, S, HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure. Viruses, 14, 2022, 657.",
                        "@reference-instance-id": "OB2BibRecID-950587919-4d984ffecd80e3566d465183af558e88-29",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127670104",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {"@first": "657"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Moini",
                                    "ce:indexed-name": "Moini M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Fung",
                                    "ce:indexed-name": "Fung S."
                                }
                            ]},
                            "ref-sourcetitle": "Viruses"
                        },
                        "ce:source-text": "Moini M, Fung S. HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure. Viruses 2022; 14: 657."
                    },
                    {
                        "ref-fulltext": "Wong, GL, Chan, HL, Tse, YK, et al. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B. J Hepatol 69 (2018), 793\u2013802.",
                        "@reference-instance-id": "OB2BibRecID-950587919-caf2e6aaaa71ec170a6657eb58f23fa4-30",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048721163",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "69"},
                                "pagerange": {
                                    "@first": "793",
                                    "@last": "802"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong G.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan H.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Tse",
                                        "ce:indexed-name": "Tse Y.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Wong GL, Chan HL, Tse YK, et al. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B. J Hepatol 2018; 69: 793\u2013802."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60073434",
            "affilname": "Beijing Ditan Hospital Capital Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073434",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60025530",
            "affilname": "Kuala Lumpur Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025530",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60014234",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008706",
            "affilname": "Peking Union Medical College Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008706",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Foster City",
            "@id": "60002909",
            "affilname": "Gilead Sciences Incorporated",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "128470234",
            "affilname": "Shanghai Public Health Clinical Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128470234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Santo Domingo",
            "@id": "120832939",
            "affilname": "Dominican Institute of Virological Studies",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120832939",
            "affiliation-country": "Dominican Republic"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85169916784",
        "dc:description": "Background: For most adults with HIV-1 and hepatitis B virus (HBV) coinfection, initial recommended treatment is a tenofovir-containing antiretroviral regimen, but no randomised studies have compared tenofovir disoproxil fumarate with tenofovir alafenamide. We aimed to investigate whether bictegravir, emtricitabine, and tenofovir alafenamide is non-inferior to dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for viral suppression in individuals with HIV-1 and HBV coinfection at 48 and 96 weeks. Methods: We did this randomised, double-blind, active-controlled, phase 3, non-inferiority trial at 46 outpatient centres in China, Dominican Republic, Hong Kong, Japan, Malaysia, South Korea, Spain, Taiwan, Thailand, Turkey, and the USA. Eligible participants were treatment-naive adults (aged ≥18 years) with plasma HIV-1 RNA of at least 500 copies per mL and plasma HBV DNA of at least 2000 IU/mL. Participants were randomly assigned (1:1) to receive daily oral bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, or dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir disoproxil fumarate 300 mg, each with corresponding matching placebo. Randomisation was stratified by hepatitis B e antigen (HBeAg) status (positive vs negative), HBV DNA (<8 vs ≥8 log10 IU/mL), and CD4 count (<50 vs ≥50 cells per μL) at screening. All investigators, participants, and staff providing treatment, assessing outcomes, and collecting data were masked to study treatment for 96 weeks. Coprimary endpoints were the proportion of participants with plasma HIV-1 RNA less than 50 copies per mL (defined by the US Food and Drug Administration snapshot algorithm) and plasma HBV DNA less than 29 IU/mL (using the missing-equals-failure approach) at week 48, with a prespecified non-inferiority margin of \u201312%. Coprimary endpoints were assessed in the full analysis set, which included all randomly assigned participants who received at least one dose of study drug and had at least one post-baseline HIV-1 RNA or HBV DNA result while on study drug. Safety endpoints were assessed in all randomly assigned participants who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, NCT03547908. Findings: Between May 30, 2018 and March 16, 2021, 381 participants were screened, of whom 243 initiated treatment (121 in the receive bictegravir, emtricitabine, and tenofovir alafenamide group; 122 in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group). At week 48, both endpoints met the criteria for non-inferiority: 113 (95%) of 119 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group and 111 (91%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group had HIV-1 RNA less than 50 copies per mL (difference 4·1, 95% CI −2·5 to 10·8; p=0·21), and 75 (63%) of 119 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group versus 53 (43%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group had HBV DNA suppression (difference 16·6, 5·9 to 27·3; nominal p=0·0023). Drug-related adverse events up to week 96 occurred in 35 (29%) of 121 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group and 34 (28%) of 122 participants in the dolutegravir, emtricitabine, and tenofovir disoproxil fumarate group. One (1%) of 121 participants in the bictegravir, emtricitabine, and tenofovir alafenamide group reported a serious adverse event (cryptococcal meningitis attributed to immune reconstitution inflammatory syndrome) that was deemed to be treatment-related. Interpretation: Coformulated bictegravir, emtricitabine, and tenofovir alafenamide is an effective therapy for adults with HIV-1 and HBV coinfection starting antiviral therapy. Funding: Gilead Sciences.",
        "pubmed-id": "37494942",
        "prism:coverDate": "2023-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85169916784",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016965",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85169916784"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85169916784&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85169916784&origin=inward"
            }
        ],
        "prism:publicationName": "The Lancet HIV",
        "source-id": "21100369870",
        "pii": "S2352301823001510",
        "citedby-count": "0",
        "subtype": "ar",
        "dc:title": "Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial",
        "openaccess": "0",
        "openaccessFlag": "false",
        "prism:doi": "10.1016/S2352-3018(23)00151-0",
        "prism:issn": "23523018",
        "publishercopyright": "© 2023 Elsevier Ltd",
        "dc:identifier": "SCOPUS_ID:85169916784",
        "dc:publisher": "Elsevier Ltd"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016965",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        },
        {
            "ce:given-name": "Hongzhou",
            "preferred-name": {
                "ce:given-name": "Hongzhou",
                "ce:initials": "H.",
                "ce:surname": "Lu",
                "ce:indexed-name": "Lu H."
            },
            "@seq": "2",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "128470234",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128470234"
            },
            "ce:degrees": "MD",
            "ce:surname": "Lu",
            "@auid": "58565355200",
            "author-url": "https://api.elsevier.com/content/author/author_id/58565355200",
            "ce:indexed-name": "Lu H."
        },
        {
            "ce:given-name": "Chee Loon",
            "preferred-name": {
                "ce:given-name": "Chee Loon",
                "ce:initials": "C.L.",
                "ce:surname": "Leong",
                "ce:indexed-name": "Leong C.L."
            },
            "@seq": "3",
            "ce:initials": "C.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025530",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025530"
            },
            "ce:degrees": "MD",
            "ce:surname": "Leong",
            "@auid": "58565355300",
            "author-url": "https://api.elsevier.com/content/author/author_id/58565355300",
            "ce:indexed-name": "Leong C.L."
        },
        {
            "ce:given-name": "Chien-Ching",
            "preferred-name": {
                "ce:given-name": "Chien Ching",
                "ce:initials": "C.C.",
                "ce:surname": "Hung",
                "ce:indexed-name": "Hung C.C."
            },
            "@seq": "4",
            "ce:initials": "C.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:degrees": "MD",
            "ce:surname": "Hung",
            "@auid": "7403166331",
            "author-url": "https://api.elsevier.com/content/author/author_id/7403166331",
            "ce:indexed-name": "Hung C.-C."
        },
        {
            "ce:given-name": "Ellen",
            "preferred-name": {
                "ce:given-name": "Ellen",
                "ce:initials": "E.",
                "ce:surname": "Koenig",
                "ce:indexed-name": "Koenig E."
            },
            "@seq": "5",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "120832939",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120832939"
            },
            "ce:degrees": "MD",
            "ce:surname": "Koenig",
            "@auid": "7005320371",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005320371",
            "ce:indexed-name": "Koenig E."
        },
        {
            "ce:given-name": "Sasisopin",
            "preferred-name": {
                "ce:given-name": "Sasisopin",
                "ce:initials": "S.",
                "ce:surname": "Kiertiburanakul",
                "ce:indexed-name": "Kiertiburanakul S."
            },
            "@seq": "6",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:degrees": "MD",
            "ce:surname": "Kiertiburanakul",
            "@auid": "6506539792",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506539792",
            "ce:indexed-name": "Kiertiburanakul S."
        },
        {
            "ce:given-name": "Man-Po",
            "preferred-name": {
                "ce:given-name": "Man Po",
                "ce:initials": "M.P.",
                "ce:surname": "Lee",
                "ce:indexed-name": "Lee M.P."
            },
            "@seq": "7",
            "ce:initials": "M.-P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60014234",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234"
            },
            "ce:degrees": "MBBS",
            "ce:surname": "Lee",
            "@auid": "56143671100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56143671100",
            "ce:indexed-name": "Lee M.-P."
        },
        {
            "ce:given-name": "Khuanchai",
            "preferred-name": {
                "ce:given-name": "Khuanchai",
                "ce:initials": "K.",
                "ce:surname": "Supparatpinyo",
                "ce:indexed-name": "Supparatpinyo K."
            },
            "@seq": "8",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:degrees": "MD",
            "ce:surname": "Supparatpinyo",
            "@auid": "6602542079",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602542079",
            "ce:indexed-name": "Supparatpinyo K."
        },
        {
            "ce:given-name": "Fujie",
            "preferred-name": {
                "ce:given-name": "Fujie",
                "ce:initials": "F.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang F."
            },
            "@seq": "9",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073434",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073434"
            },
            "ce:degrees": "MD",
            "ce:surname": "Zhang",
            "@auid": "55503803800",
            "author-url": "https://api.elsevier.com/content/author/author_id/55503803800",
            "ce:indexed-name": "Zhang F."
        },
        {
            "ce:given-name": "Sophia",
            "preferred-name": {
                "ce:given-name": "Sophia",
                "ce:initials": "S.",
                "ce:surname": "Rahman",
                "ce:indexed-name": "Rahman S."
            },
            "@seq": "10",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "MPH",
            "ce:surname": "Rahman",
            "@auid": "58565182900",
            "author-url": "https://api.elsevier.com/content/author/author_id/58565182900",
            "ce:indexed-name": "Rahman S."
        },
        {
            "ce:given-name": "Michelle L",
            "preferred-name": {
                "ce:given-name": "Michelle L.",
                "ce:initials": "M.L.",
                "ce:surname": "D'Antoni",
                "ce:indexed-name": "D'Antoni M.L."
            },
            "@seq": "11",
            "ce:initials": "M.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "PhD",
            "ce:surname": "D'Antoni",
            "@auid": "24068794700",
            "author-url": "https://api.elsevier.com/content/author/author_id/24068794700",
            "ce:indexed-name": "D'Antoni M.L."
        },
        {
            "ce:given-name": "Hongyuan",
            "preferred-name": {
                "ce:given-name": "Hongyuan",
                "ce:initials": "H.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang H."
            },
            "@seq": "12",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Wang",
            "@auid": "58566213400",
            "author-url": "https://api.elsevier.com/content/author/author_id/58566213400",
            "ce:indexed-name": "Wang H."
        },
        {
            "ce:given-name": "Jason T",
            "preferred-name": {
                "ce:given-name": "Jason T.",
                "ce:initials": "J.T.",
                "ce:surname": "Hindman",
                "ce:indexed-name": "Hindman J.T."
            },
            "@seq": "13",
            "ce:initials": "J.T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "PharmD",
            "ce:surname": "Hindman",
            "@auid": "53864807100",
            "author-url": "https://api.elsevier.com/content/author/author_id/53864807100",
            "ce:indexed-name": "Hindman J.T."
        },
        {
            "ce:given-name": "Hal",
            "preferred-name": {
                "ce:given-name": "Hal",
                "ce:initials": "H.",
                "ce:surname": "Martin",
                "ce:indexed-name": "Martin H."
            },
            "@seq": "14",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "MD",
            "ce:surname": "Martin",
            "@auid": "56173399700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56173399700",
            "ce:indexed-name": "Martin H."
        },
        {
            "ce:given-name": "Jared M",
            "preferred-name": {
                "ce:given-name": "Jared M.",
                "ce:initials": "J.M.",
                "ce:surname": "Baeten",
                "ce:indexed-name": "Baeten J.M."
            },
            "@seq": "15",
            "ce:initials": "J.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002909",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909"
            },
            "ce:degrees": "MD",
            "ce:surname": "Baeten",
            "@auid": "7003812564",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003812564",
            "ce:indexed-name": "Baeten J.M."
        },
        {
            "ce:given-name": "Taisheng",
            "preferred-name": {
                "ce:given-name": "Taisheng",
                "ce:initials": "T.",
                "ce:surname": "Li",
                "ce:indexed-name": "Li T."
            },
            "@seq": "16",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008706",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008706"
            },
            "ce:degrees": "MD",
            "ce:surname": "Li",
            "@auid": "8876653800",
            "author-url": "https://api.elsevier.com/content/author/author_id/8876653800",
            "ce:indexed-name": "Li T."
        }
    ]}
}}